Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Columbia Care Inc.
  6. News
  7. Summary
    CCHW   CA1973091079

COLUMBIA CARE INC.

(CCHW)
  Report
Delayed Quote. Delayed CANADIAN NATIONAL STOCK EXCHANGE - 09/27 03:59:30 pm
5.07 CAD   -3.43%
09/09COLUMBIA CARE : Celebrates the Start of Whole Flower Cannabis Sales in Virginia
BU
09/02COLUMBIA CARE : to Rebrand as Cannabist in Florida
BU
09/02Columbia Care to Rebrand as Cannabist in Florida
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Columbia Care : Announces Closing of US$74.5 Million Private Placement Offering of 6.00% Secured Convertible Notes Due 2025

06/29/2021 | 09:08am EDT

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) is pleased to announce that it has closed its previously announced private placement (the “Offering”) issuing US$74,500,000 aggregate principal amount of 6.00% secured convertible notes due 2025 (the “Notes”).

The Offering was conducted on a “best-efforts” basis pursuant to an agency agreement entered into on June 17, 2021 between the Company and a syndicate of agents. Canaccord Genuity acted as sole bookrunner and co-lead agent for the Offering, and ATB Capital Markets acted as co-lead agent for the offering. A.G.P./Alliance Global Partners acted as financial advisor.

The Notes are senior secured obligations of the Company and will accrue interest payable semi-annually in arrears and mature on June 29, 2025, unless earlier converted, redeemed or repurchased. The conversion rate will be 154 common shares of the Company (“Common Shares”) per $1,000 principal amount of Notes (equivalent to a price of approximately US$6.49 per Common Share), subject to customary adjustments. The conversion price of the Notes represents a premium of approximately 25% over the closing price of the Common Shares on the NEO Exchange on June 17, 2021.

The Company may redeem the Notes at par, in whole or in part, on or after June 29, 2023, if the volume weighted average price of the Common Shares trading on the Canadian Stock Exchange or the NEO Exchange for 15 of the 30 trading days immediately preceding the day on which the Company exercises its redemption right, exceeds 120% of the conversion price of the Notes.

The Notes were offered for sale on a private placement basis in certain provinces of Canada pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws. The Notes may also be sold in the United States to or for the account or benefit of “U.S. persons” (as defined in the United States Securities Act of 1933, as amended) (the “U.S. Securities Act”), on a private placement basis to “qualified institutional buyers” pursuant to an exemption from the registration requirements of the U.S. Securities Act, and in such jurisdictions outside of Canada and the United States as may be agreed upon by Canaccord and the Company, in each case in accordance with applicable laws. The Notes issued are subject to a customary four-month hold period under Canadian securities laws.

The net proceeds from the Offering will be used for working capital and general corporate purposes.

No securities regulatory authority has either approved or disapproved of the contents of this news release. The Notes have not been and will not be registered under the U.S. Securities Act or any state securities laws. Accordingly, the Notes may not be offered or sold within the United States or to or for the account or benefit of “U.S. persons” unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 US jurisdictions and the EU. Columbia Care currently operates 122 facilities1 including 92 dispensaries and 30 cultivation and manufacturing facilities. Columbia Care is one of the original providers of medical cannabis in the United States, and continues to deliver industry-leading products and services. The company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. Through its dispensary network, the company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. Columbia Care is known for setting the standard for compassion, professionalism, quality, care, and innovation in the rapidly expanding cannabis industry. For more information on Columbia Care, please visit www.col-care.com.

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws (“forward-looking statements”). Statements concerning Columbia Care’s objectives, goals, strategies, priorities, intentions, plans, beliefs, expectations and estimates, and the business, operations, financial performance and condition of Columbia Care as well as statements relating to the closing of the Offering and the use of proceeds thereof. The words “believe”, “expect”, “anticipate”, “estimate”, “intend”, “may”, “will”, “would”, “could”, “should”, “continue”, “plan”, “goal”, “objective”, and similar expressions and the negative of such expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

The purpose of forward-looking statements is to provide the reader with a description of management's expectations, and such forward-looking statements may not be appropriate for any other purpose. In particular, but without limiting the foregoing, disclosure in this press release as well as statements regarding the Company's objectives, plans and goals, including future operating results and economic performance may make reference to or involve forward-looking statements. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. A number of factors could cause actual events, performance or results to differ materially from what is projected in the forward-looking statements. No undue reliance should be placed on forward-looking statements contained in this press release. Such forward looking statements are made as of the date of this press release. Columbia Care undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. The Company's forward-looking statements are expressly qualified in their entirety by this cautionary statement.


1 Pro forma facilities either open or under development; includes facilities where Columbia Care provides consultative services pursuant to the terms of a management service agreement


ę Business Wire 2021
All news about COLUMBIA CARE INC.
09/09COLUMBIA CARE : Celebrates the Start of Whole Flower Cannabis Sales in Virginia
BU
09/02COLUMBIA CARE : to Rebrand as Cannabist in Florida
BU
09/02Columbia Care to Rebrand as Cannabist in Florida
CI
08/16COLUMBIA CARE : Expands New Jersey Footprint with New Dispensary in Deptford, Bringing Sca..
BU
08/16Columbia Care Inc. Expands New Jersey Footprint with New Dispensary in Deptford, Bringi..
CI
08/16Columbia Care Inc. acquired Corsa Verde LLC for approximately $2.7 million.
CI
08/12Columbia Care Inc. Reaffirms Revenue Guidance for 2021
CI
08/12COLUMBIA CARE : Reports Record Second Quarter 2021 Results
BU
08/12Columbia Care Inc. Reports Unaudited Consolidated Earnings Results for the Second Quart..
CI
08/10COLUMBIA CARE : Commences Adult Use Sales at Downtown Boston Dispensary
BU
More news
Financials (USD)
Sales 2021 518 M - -
Net income 2021 -17,6 M - -
Net Debt 2021 235 M - -
P/E ratio 2021 -100x
Yield 2021 -
Capitalization 1 468 M 1 467 M -
EV / Sales 2021 3,29x
EV / Sales 2022 2,04x
Nbr of Employees -
Free-Float 58,9%
Chart COLUMBIA CARE INC.
Duration : Period :
Columbia Care Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 4,01 $
Average target price 11,46 $
Spread / Average Target 185%
EPS Revisions
Managers and Directors
Nicholas Keane Vita Vice Chairman & Chief Executive Officer
Michael Livingstone Chief Financial Officer, VP & Controller
Michael Abbott Executive Chairman
Rosemary Mazanet Chief Scientific Officer
David James Hart Chief Operating Officer
Sector and Competitors